U.S. markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1300-0.0300 (-2.59%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/24/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.30
52-Week Change 3-0.88%
S&P500 52-Week Change 336.19%
52 Week High 32.9950
52 Week Low 30.4510
50-Day Moving Average 31.6635
200-Day Moving Average 31.4952

Share Statistics

Avg Vol (3 month) 312.83M
Avg Vol (10 day) 39.02M
Shares Outstanding 5179.14M
Implied Shares Outstanding 6N/A
Float 176.16M
% Held by Insiders 10.59%
% Held by Institutions 19.49%
Shares Short (Jun 29, 2021) 43.65M
Short Ratio (Jun 29, 2021) 40.26
Short % of Float (Jun 29, 2021) 42.14%
Short % of Shares Outstanding (Jun 29, 2021) 42.04%
Shares Short (prior month May 27, 2021) 42.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.91%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.92M
Net Income Avi to Common (ttm)-134.83M
Diluted EPS (ttm)-2.6600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.78M
Total Cash Per Share (mrq)0.57
Total Debt (mrq)47.11M
Total Debt/Equity (mrq)149.47
Current Ratio (mrq)2.38
Book Value Per Share (mrq)0.18

Cash Flow Statement

Operating Cash Flow (ttm)-28.27M
Levered Free Cash Flow (ttm)-12.46M